Skip to main content
Fig. 3 | Annals of Intensive Care

Fig. 3

From: Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial

Fig. 3

Effect of CYT107 on circulating cytokines. Plasma concentration at day 1 and day 15 of the pro-inflammatory cytokines IL-6 (A, B) and TNF-a (C, D) and the anti-inflammatory cytokine IL-10 (E, F). Placebo group individuals are in blue. Patients that received CYT107 and had a respiratory event are in black. Patients that received CYT107 and did not have a respiratory event are in red

Back to article page